Artificial intelligence-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessment | HTE12 | | |
Digital technologies to support self-management of COPD: early value assessment | HTE19 | | |
Artificial intelligence technologies to help detect fractures on X-rays in urgent care: early value assessment | HTE20 | | |
Digitally enabled therapies for adults with depression: early value assessment | HTE8 | | |
Digital technologies to deliver pulmonary rehabilitation programmes for adults with COPD: early value assessment | HTE18 | | |
Digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people: early value assessment | HTE17 | | |
ProKnow cloud-based system for radiotherapy data storage, communication and management: early value assessment | HTE5 | | |
Digital technologies for delivering multidisciplinary weight-management services: early value assessment | HTE14 | | |
Digital technologies for managing non-specific low back pain: early value assessment | HTE16 | | |
Digitally enabled therapies for adults with anxiety disorders: early value assessment | HTE9 | | |
Virtual reality technologies for treating agoraphobia or agoraphobic avoidance: early value assessment | HTE15 | | |
Virtual ward platform technologies for acute respiratory infections: early value assessment | HTE13 | | |
Artificial intelligence technologies to aid contouring for radiotherapy treatment planning: early value assessment | HTE11 | | |
KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medication: early value assessment | HTE10 | | |
Guided self-help digital cognitive behavioural therapy for children and young people with mild to moderate symptoms of anxiety or low mood: early value assessment | HTE3 | | |
Genedrive MT-RNR1 ID Kit for detecting a genetic variant to guide antibiotic use and prevent hearing loss in babies: early value assessment | HTE6 | | |
Point-of-care tests for urinary tract infections to improve antimicrobial prescribing: early value assessment | HTE7 | | |
CaRi-Heart for predicting cardiac risk in suspected coronary artery disease: early value assessment | HTE4 | | |
Cefiderocol for treating severe drug-resistant gram-negative bacterial infections | HTE2 | | |
Ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections | HTE1 | | |